Commercial agreement

 

TIDMONG 
 
RNS Number : 5389S 
Oxford Nutrascience Group PLC 
13 September 2010 
 

Oxford Nutrascience Group plc 
("Oxford Nutrascience" or "the Company") 
 
Commercial agreement with leading provider of outsourced services to the health 
and beauty markets 
 
Oxford Nutrascience has signed a non-exclusive commercial agreement for its 
Chewitab(TM) technology with DCC Health & Beauty Solutions Ltd., the leading 
provider of outsourced services to the health and beauty markets. Oxford 
Nutrascience will earn royalties on all Chewitab enabled products sold by DCC 
Health & Beauty Solutions in the UK and Ireland. 
 
Under the terms of the open-ended agreement DCC Health & Beauty Solutions will 
license Oxford Nutrascience's technology for the manufacture and sale of 
chewable tablets. DCC Health & Beauty Solutions will have the ability to use 
Chewitab for an unlimited range of applications, including the production of 
healthcare supplements. 
 
DCC Health & Beauty Solutions provides services to leading premium brand owners, 
mail order companies and global health and beauty retailers. Their customer base 
includes; Merck, GSK, Healthspan and Vitabiotics. 
 
Chewitab is Oxford Nutrascience's proprietary technology used in chewable 
tablets. Chewitabs  produce a light crunch when bitten and dissolve quickly in 
the mouth resulting in a soft pleasant mouth feel with no grittiness and can be 
taken without water. 
 
This key differentiator makes Chewitabs a highly convenient delivery system and 
particularly well suited for Over The Counter medicines (such as analgesics, 
allergy treatments, digestive aids) and medicines for the elderly as well as 
vitamins and supplements. 
 
DCC Health & Beauty Solutions is part of DCC plc, a business support services 
group listed on the Irish and London Stock Exchanges with revenues of EUR6.7 
billion. DCC Health & Beauty Solutions is a high growth business, driven by its 
proactive approach to new product development, its ability to react quickly to 
market dynamics and the quality of its MHRA licenced facilities. It provides 
services to the companies behind many of the most successful supplement brands 
on the shelves in the UK today. 
 
Nigel Theobald, Chief Executive, Oxford Nutrascience Group Plc commented: 
 
"Securing a licensing agreement for Chewitab with the UK's largest healthcare 
contract supplier so soon since the IPO of the Company demonstrates the strength 
of our business model and validates the efficacy of our technology. 
 
"The interest being shown by a number of global healthcare companies in our 
chewable and soluble products is being fueled by healthcare organisations 
striving to find ways to extend their product life cycles. This is creating 
growing demand for more innovative delivery systems and superior product 
performance and Chewitab provides a solution to this challenge. 
 
"DCC Health & Beauty Solutions have an outstanding track record of exploiting 
markets with high performing products and we look forward to exploring other 
products ideas with them." 
 
 
Rachell Hipkiss, Development Director, DCC Health & Beauty Solutions, commented: 
 
 
"DCC Health & Beauty Solutions specialises in the provision of outsourced 
product development, manufacturing, packing and other services to the health and 
beauty industry in Europe. 
 
"Oxford Nutrascience, with its innovative ideas, fits perfectly with the 
objective of DCC Health & Beauty Solutions of bringing exciting new solutions to 
market. We are excited about the prospects for Chewitab and look forward to 
working with our customers to launch of our Chewitab based products." 
 
 
For further information: 
 
Oxford Nutrascience Group Plc 
Nigel Theobald, Chief Executive                                     +44 1865 
854874 
Mark Way, Investor and Media Relations                        [phone] 
 
DCC Health & Beauty Solutions Ltd                               [phone] 
Rachell Hipkiss, Development Director 
 
ZAI Corporate Finance (Nominated Adviser) 
Ray Zimmerman                                                           +44 20 
7060 2220 
Sarang Shah                                                                +44 
20 7060 2220 
 
 
About Oxford Nutrascience Group Plc 
 
www.oxfordnutrascience.com 
 
·      Oxford Nutrascience is a UK consumer healthcare company that develops 
chewy confectionery, chewable tablets and liquid suspensions to allow medicines 
and vitamin supplements to be taken in a more pleasant and convenient way. 
 
·      Oxford Nutrascience has developed technology for the use of soluble 
fibres in medicine delivery systems that disperse and solubilise medicines, 
improve taste and mouth feel, simplify processing and eliminate additives, 
incorporate prebiotic health benefits. 
 
·      Chews: Oxford Nutrascience currently produces Ellactiva , a calcium chewy 
supplement sold in the UK and in the Middle East, and plans to launch new chews 
to complement this existing product. 
 
·      Chewable tablets and liquid suspensions: The target market for Oxford 
Nutrasciences' Chewitabs(TM) and liquid suspension delivery systems are 
over-the-counter ("OTC") pain relieving drugs, indigestion preparations and 
cough and cold medicines. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 AGREAANAFESEEAF